Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8 PF-07321332 Boceprevir Pakati

Tsanangudzo Pfupi

Kemikari Zita: Methyl (S) -2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate

CAS: 328086-60-8

Chitarisiko: Muchena kusvika Kuchena-Upfu

Pakati pePF-07321332 Paxlovid (CAS 2628280-40-8) uye Boceprevir (CAS 394730-60-0)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name Methyl (S) -2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate
Mashoko anoreva zvakafanana Methyl (S) -2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate;(αS,3S) -α--[(tert-Butyloxycarbonyl)aMino]-2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate
Nhamba yeCAS 328086-60-8
Nhamba yeCAT RF-PI317
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram
Molecular Formula C13H22N2O5
Molecular Weight 286.33
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kusvika kuOff-White Powder
Identification A IR: Yakafanana neReference Substance
Kuzivikanwa B Nguva Yekuchengeta: Yakafanana neReference Substance
Kurasika paKuomesa ≤1.0%
Residue paIgnition ≤0.20%
Kusachena Kumwechete ≤0.50%
Zvose Zvisina Kuchena ≤2.0%
Masimbi anorema (Pb) ≤20ppm
Kuchena ≥98.0%
Test Standard Enterprise Standard
Usage Pakati pePF-07321332 Paxlovid (CAS 2628280-40-8) uye Boceprevir (CAS 394730-60-0)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

Methyl (S) -2- (Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate (CAS 328086-60-8) iri pakati pePF-07321332 Paxlovid (CAS 2628280-40 -8) uye Boceprevir (CAS 394730-60-0).PF-07321332, chikamu chakakosha chePaxlovid (PF-07321332 uye Ritonavir) inova yekuongorora COVID-19 yemuromo antiviral mumiriri, ndeye nemuromo bioavailable 3C-senge protease (3CLPRO) inhibitor ine simba antiviral mhedzisiro kurwisa hutachiona hweSARS-CoV-2. uye COVID-19.Musi waNove 6, 2021, Pfizer akazivisa kuti Paxlovid akadzikisa zvakanyanya kuchipatara uye kufa, zvichibva pakuongororwa kwechinguvana kwechikamu chechipiri chechikamu chechipiri EPIC-HR (Kuongorora kweProtease Inhibition yeCOVID-19 muVarwere Vepamusoro-soro) yevarwere vakura vasiri muchipatara vane COVID-19, vari panjodzi huru yekuenderera mberi nehurwere hwakanyanya.Boceprevir (EBP-520) iHCV protease inhibitor (Ki = 14 nM) yekurapa hutachiona hwehepatitis C.Boceprevir ine pegylated interferon uye ribavirin (PegIFN/RBV) yakagonesa kuvandudzwa mukuchengetedzwa kwehutachiona hwehutachiona hwevarwere vane genotype 1 HCV.Boceprevir inosangana ne immunosuppressive therapy (IT) nekudzivisa cytochrome P450 3A enzyme.

Nyora meseji yako pano uye titumire kwatiri